Brenk lab
Research funding from NFR

Chartering chemical space of riboswitch ligands - towards future antibiotics

The Brenk lab will receive funding from NFR for developing future antibiotics acting via riboswitch binding. This project will fund two postdoc positions for three years, one in the lab of Bengt Erik Haug (Department of Chemistry) and one in the Brenk group. We are looking forward to continuing an exiting research project!

Ribocil bound to FMN riboswitch